Looking to expand your partner network with the latest in the field of GMO? Consider joining Inpart's global network for free.
News and Trends 8 Sep 2022
CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September 8) they have a new structure to their 2018 strategic alliance in the CRISPR/Cas9 field. In 2018, science and technology company Merck, of which Sigma-Aldrich is a subsidiary, announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based […]